Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Rheumatology for the Future - Precision medicine in chronic immune-mediated rheumatic diseases

Reference number
Coordinator Region Stockholm - Karolinska Universitetssjukhuset
Funding from Vinnova SEK 16 000 000
Project duration September 2024 - September 2027
Status Ongoing
Venture Utlysning Framtidens Precisionsmedicin
Call The precision medicine of the future

Purpose and goal

To create a precision medicine innovation environment that transforms the management of immune-mediated rheumatic diseases from today’s too late and too imprecise diagnosis and lifelong treatment into earlier diagnosis, curative therapies and prevention.

Expected effects and result

Fewer and healthier patients, and a competitive Swedish arena enabling our solutions to be used and commercialized also in the rest of the world.

Planned approach and implementation

Collaboration between the private sector, academia, health-care and patients. Precision-diagnostics building on improved understanding of the underlying immune reactions in immune-mediated rheumatic diseases. Integration of this precision-diagnostics into our quality register and digital support system. Use of these new diagnostics and register infrastructure to test and implement new diagnostics and precision therapy. Leverage learnings from our ongoing Vinnova environment.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 24 September 2024

Reference number 2024-01145